2019 Second International Fetal Heart Symposium

总结 该申请要求资助2019年第二届国际胎儿心脏 研讨会定于4月25日至27日举行。2019.本次研讨会包括相关主题 胎儿心脏，新的成像方式和新的进展，如干细胞移植， 先天性心脏病它的重点是提高对心脏背后的遗传病因学的理解 缺陷，了解胎儿心脏形成机制，新影像学的应用 心脏缺损的早期诊断方法及组织工程的应用 技术，以改善手术结果，特别是在单心室修复。 先天性心脏病是胎儿最常见的心脏结构异常 发病率为6-8/1000。冠心病的病因可分为遗传性和环境性 因素和大多数研究表明，它可能是多因素的。尽管如此，70%的CHD 发生不明原因。众所周知，产前CHD检测可改善 产后结果;因此，子宫内诊断对计划怀孕很重要。因为 围产期医学是一个多学科领域，研讨会的目标是汇集基本的 科学家、放射科医生、超声技师、遗传学家、围产期专家、儿科心脏病专家、心脏 外科医生，医学生和护士讨论筛查方法，早期发现，新的 成像模式和结果的改善。 拟议的2.5天研讨会包括有组织的教学会议和促进 学习本次研讨会的六个具体目标是：1）展示改进的实践 关于先天性心脏病的重要概念的策略。2)定义 成像技术的进步。3)在诊断方面表现出更强的能力， 胎儿心脏异常的处理。4)描述筛查的最新进展， 先天性心脏病的诊断和治疗。5)描述最相关的额外 心脏异常沿着心脏缺陷，并学习如何管理孕妇产前。 6)展示出生后管理和干细胞治疗在主要心脏病中的新进展 缺陷 发言者将包括资深调查员，在他们的胎儿和 儿科心脏病学遗传学和心脏外科实践环节将解决实际问题， 胎儿超声心动图的应用技巧，并了解不同的多普勒模式， 评估心脏功能。

SUMMARY This application requests funds for support of the 2019 Second International Fetal Heart Symposium event scheduled for April 25-27. 2019. This Symposium encompasses topics related to fetal heart, new imaging modalities and new advances such as stem cell transplantation in congenital heart defects. Its focus is to improve understanding the genetic etiology behind heart defects, understanding the mechanisms of fetal heart formation, application of new imaging modalities to detect heart defects as early as possible and application of tissue engineering techniques to improve surgical outcomes, especially in single ventricular repair. Congenital heart defects (CHD) are the most common structural abnormalities in the fetus with an incidence of 6-8/1000. The etiology of CHD can be divided into genetic and environmental factors and most of the studies indicate that it could be multifactorial. In spite of that, 70% of CHD occur for unknown reasons. It is very well known that prenatal detection of CHD improves postnatal outcomes; therefore, diagnosis in utero is important to plan the pregnancy. Because perinatal medicine is a multidisciplinary field, the goal of the Symposium is to bring together basic scientists, radiologists, sonographers, geneticists, perinatologists, pediatric cardiologists, cardiac surgeons, medical students, and nurses to discuss the screening methods, early detection, new imaging modalities and improvements in outcomes. The proposed 2.5 day Symposium includes organized didactic sessions and facilitative learning. The six specific goals of this symposium are: 1) Demonstrate improved practice strategies regarding the important concepts of congenital heart disease. 2) Define the advancements in imaging technology. 3) Demonstrate greater competence in the diagnosis and management of fetal cardiac abnormalities. 4) Describe the latest advances in screening, diagnosing and treatment of congenital heart diseases. 5) Describe the most associated extra cardiac anomalies along with heart defects and learn how to manage pregnant women prenatally. 6) Demonstrate new advances in postnatal management and stem cell therapy in major cardiac defects. Speakers will include senior investigators, well established in their fields of fetal and pediatric cardiology, genetics and cardiac surgery. The Hands-on session will address practical tips of fetal echocardiography application, and understanding the different Doppler modalities in assessments of cardiac function.